Intensive Blood-Pressure Control in Patients with Type 2 Diabetes
2024 · New England Journal of Medicine · 160 citations
https://doi.org/10.1056/nejmoa2412006
F
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
23
Papers
505
Citations
9
h-index
9
i10-index
Fengmei Xu is an academic researcher from Hefei Design and Research Institute of Coal Industry (China). The author has contributed to research in topics: Diabetes Treatment and Management & Diabetes Management and Research & Blood Pressure and Hypertension Studies. The author has an h-index of 9, co-authored 20 publications.
Papers by this author
workshnRNPK inhibits GSK3β Ser9 phosphorylation, thereby stabilizing c-FLIP and contributes to TRAIL resistance in H1299 lung adenocarcinoma cells
2016 · Scientific Reports · 29 citations
https://doi.org/10.1038/srep22999
HemK2 functions for sufficient protein synthesis and RNA stability through eRF1 methylation during <i>Drosophila</i> oogenesis
2024 · Development · 6 citations
https://doi.org/10.1242/dev.202795
Cumulative blood pressure load as a predictor of arterial stiffness progression and incident diabetic kidney disease: a multicenter longitudinal study
2025 · Cardiovascular Diabetology · 1 citations
https://doi.org/10.1186/s12933-025-02785-7
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat